Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

Ursodeoxycholic acid (UDCA) is widely used for the treatment of chronic cholestatic ... high-dose UDCA in patients with primary sclerosing cholangitis (PSC) may be harmful; adverse events, such ...

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

An antibiotic used to treat infective diarrhoea may be an effective drug for a type of inflammatory bowel disease, according ...

By Tarun Sai Lomte A four-week treatment with oral vancomycin led to clinical remission in PSC-IBD patients, accompanied by ...

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

Livdelzi (seladelpar) is a medicine that can treat primary biliary cholangitis (PBC) by reducing the amount of bile in your body. It does this by signaling the body to stop making bile acid.

Medically reviewed by Jay N. Yepuri, MD Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ...